Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies
Alternative splicing is an essential regulatory mechanism for gene expression in mammalian cells contributing to protein, cellular, and species diversity. In cancer, alternative splicing is frequently disturbed, leading to changes in the expression of alternatively spliced protein isoforms. Advances...
Guardado en:
Autores principales: | Tülay Karakulak, Holger Moch, Christian von Mering, Abdullah Kahraman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b81a7f5d0cbe4d7aadd5452cb9527017 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy
por: Xiujing He, et al.
Publicado: (2021) -
Full-length transcript sequencing of human and mouse cerebral cortex identifies widespread isoform diversity and alternative splicing
por: Szi Kay Leung, et al.
Publicado: (2021) -
The Alternatively Spliced Isoforms of Key Molecules in the cGAS-STING Signaling Pathway
por: Jiaqian Liang, et al.
Publicado: (2021) -
Comprehensive Combined Proteomics and Genomics Analysis Identifies Prognostic Related Transcription Factors in Breast Cancer and Explores the Role of DMAP1 in Breast Cancer
por: Xuan Li, et al.
Publicado: (2021) -
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
por: Veronica Vella, et al.
Publicado: (2021)